Charles River Laboratories International, Inc. (NYSE:CRL) Q4

Charles River Laboratories International, Inc. (NYSE:CRL) Q4 2023 Earnings Call Transcript February 14, 2024 Charles River Laboratories International, Inc. beats earnings expectations. Reported EPS is $2.46, expectations were $2.39. Charles River Laboratories International, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details […]

Related Keywords

Mauritius , Todd Spencer , Flavia Pease , Kristen Eisenhauer , Manufacturing Solutions , Microbial Solutions , Endo Safe Nexus , Investor Day , Bill Barbo , Executive Vice President , Chief Commercial Officer , Charles River , Senior Vice President , Biologics Testing , Bike Brands According , Football Clubs , Charles River Laboratories , Revenue Growth , Fourth Quarter , Basis Points , Operating Margin , Arnings Per Share ,